These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31476712)

  • 1. Structural, functional, and neurochemical neuroimaging of methamphetamine-associated psychosis: A systematic review.
    Chen C; Hsu FC; Li CW; Huang MC
    Psychiatry Res Neuroimaging; 2019 Oct; 292():23-31. PubMed ID: 31476712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine use and cognitive function: A systematic review of neuroimaging research.
    Sabrini S; Wang GY; Lin JC; Ian JK; Curley LE
    Drug Alcohol Depend; 2019 Jan; 194():75-87. PubMed ID: 30414539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction time variability and related brain activity in methamphetamine psychosis.
    Fassbender C; Lesh TA; Ursu S; Salo R
    Biol Psychiatry; 2015 Mar; 77(5):465-74. PubMed ID: 25444164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
    Okada N; Takahashi K; Nishimura Y; Koike S; Ishii-Takahashi A; Sakakibara E; Satomura Y; Kinoshita A; Takizawa R; Kawasaki S; Nakakita M; Ohtani T; Okazaki Y; Kasai K
    Addict Biol; 2016 Mar; 21(2):489-503. PubMed ID: 25619621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of Voxel-Based Morphometric Brain Volumes of Individuals with Methamphetamine-Induced Psychotic Disorder and Schizophrenia Spectrum Disorder and Healthy Controls.
    Farnia V; Farshchian F; Farshchian N; Alikhani M; Sadeghi Bahmani D; Brand S
    Neuropsychobiology; 2020; 79(2):170-178. PubMed ID: 31794972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Gray Matter Density, Regional Homogeneity, and Functional Connectivity in Methamphetamine-Associated Psychosis: A Resting-State Functional Magnetic Resonance Imaging (fMRI) Study.
    Zhang S; Hu Q; Tang T; Liu C; Li C; Zang YY; Cai WX
    Med Sci Monit; 2018 Jun; 24():4020-4030. PubMed ID: 29897049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia.
    Alexander PD; Gicas KM; Cheng A; Lang DJ; Procyshyn RM; Vertinsky AT; Panenka WJ; Thornton AE; Rauscher A; Wong JYX; Chan T; Jones AA; Vila-Rodriguez F; Honer WG; Barr AM
    Psychopharmacology (Berl); 2019 Dec; 236(12):3385-3399. PubMed ID: 31230145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-associated psychosis.
    Grant KM; LeVan TD; Wells SM; Li M; Stoltenberg SF; Gendelman HE; Carlo G; Bevins RA
    J Neuroimmune Pharmacol; 2012 Mar; 7(1):113-39. PubMed ID: 21728034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis.
    Orikabe L; Yamasue H; Inoue H; Takayanagi Y; Mozue Y; Sudo Y; Ishii T; Itokawa M; Suzuki M; Kurachi M; Okazaki Y; Kasai K
    Schizophr Res; 2011 Nov; 132(2-3):183-9. PubMed ID: 21784619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis: noradrenergic hyperactivity with contribution from dopaminergic hyperactivity.
    Yui K; Goto K; Ikemoto S; Ishiguro T; Kamata Y
    J Clin Psychopharmacol; 2000 Apr; 20(2):165-74. PubMed ID: 10770454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denial in methamphetamine users: Associations with cognition and functional connectivity in brain.
    Dean AC; Kohno M; Morales AM; Ghahremani DG; London ED
    Drug Alcohol Depend; 2015 Jun; 151():84-91. PubMed ID: 25840750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural brain network development in children following prenatal methamphetamine exposure.
    Roos A; Fouche JP; du Toit S; du Plessis S; Stein DJ; Donald KA
    J Comp Neurol; 2020 Jul; 528(11):1856-1863. PubMed ID: 31953852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.
    Chang L; Alicata D; Ernst T; Volkow N
    Addiction; 2007 Apr; 102 Suppl 1():16-32. PubMed ID: 17493050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users.
    Willi TS; Lang DJ; Honer WG; Smith GN; Thornton AE; Panenka WJ; Procyshyn RM; Vila-Rodriguez F; Su W; Vertinsky AT; Leonova O; Rauscher A; MacEwan GW; Barr AM
    Schizophr Res; 2016 Oct; 176(2-3):158-163. PubMed ID: 27499362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of risk factors for methamphetamine-associated psychosis.
    Arunogiri S; Foulds JA; McKetin R; Lubman DI
    Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study.
    Hadizadeh H; Salehi M; Bozorgnia AR; Ahmadkhaniha HR
    Drug Alcohol Depend; 2020 Feb; 207():107682. PubMed ID: 31841749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for treatment-resistive methamphetamine psychosis.
    Fujii D
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):239-40. PubMed ID: 11983802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.